Phthalates in medical devices for parenteral and enteral nutrition;Les phtalates dans les dispositifs médicaux destinés à la nutrition artificielle

Nutrition Clinique et Metabolisme

Volumn 25, Issue 1, 2011, Pages 15-23

  Bagel, Sandrine ^a   Décaudin, Bertrand ^b,c   Neuville, Sébastien ^b   Chopineau, Jean ^a,d   Odou, Pascal ^b,c   Sautou, Valérie ^a,d  

^a SERVICE DE RHUMATOLOGIE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Cité scientifique   (France)

^d UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

DEHP; Medical devices; Plasticizers; Polyvinyl chloride

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE;

ALTERNATIVE MEDICINE; ENTERIC FEEDING; FEEDING APPARATUS; GOVERNMENT REGULATION; HEALTH PRACTITIONER; HUMAN; PARENTERAL NUTRITION; REVIEW; TOXICOLOGICAL PARAMETERS;

EID: 79951576149     PISSN: 09850562     EISSN: 17683092     Source Type: Journal    
DOI: 10.1016/j.nupar.2010.11.001     Document Type: Review

References (50)

1. Direction de la qualité du médicament & soins de santé du Conseil de l'Europe. Matériaux à base de poly(chlorure de vinyle) plastifié pour récipients destinés à contenir les solutions aqueuses pour perfusion intraveineuse. Pharmacopée européenne, 6e édition; 2010.
2. Institut national de recherche et de sécurité pour la prévention des accidents du travail et des maladies professionnelles (INRS). Point des connaissances sur les phtalates. ED5010. INRS; 2004.
3. European Food Safety Authority (EFSA). Statement of the scientific panel on food additives, flavouring, processing aids and materials in contact with food (AFC panel) on the reclassification of some phthalates for consistency with the new SCF guidelines for food contact materials. Parma EFSA; 2004.
4. Loff S., Kabs F., Witt K., Sartoris J., Mandl B., Niessen K.H., et al. Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers. J Pediatr Surg 2000, 35:1775-1781.
5. US Food and Drug Administration. Safety assessment of di(2-ethylhexyl)phthlate (DEHP) release from medical devices. Rockville, MD: FDA; 2001.
6. Dalle M., Sautou-Miranda V., Balayssac D., Bourlon S., Bagel S., Chopineau J. Peut-on conditionner les solutions de docétaxel dans des poches en PVC ?. J Pharm Clin 2006, 25:147-152.
7. Scientific Committee on Emerging and Newly-Identified Health Risks (SCENIHR). Opinion on the safety of medical devices containing dehpplasticized PVC or orther plasticizers on neonate and other groups possibly at risk. Commission européenne; 2008.
8. Kambia K., Dine T., Gressier B., Bah S., Germe A.F., Luyckx M., et al. Evaluation of childhood exposure to di(2-ethylhexyl) phthalate from perfusion kits during long-term parenteral nutrition. Int J Pharm 2003, 262:83-91.
9. Bagel-Boithias S, Dessaigne B, Bourdeaux D, Chopineau J, Sautou V. Influence du type de lipide entrant dans la composition des mélanges nutritifs parentéraux sur le relargage du DEHP. Congrès Europharmat 2009 oct 13-15; Strasbourg.
10. Takatori S., Okamoto Y., Kitawaga Y., Hori S., Izumi S.I., Makino T., et al. Simulated neonatal exposure to DEHP and MEHP from PVC enteral nutrition products. Int J Pharm 2008, 352:139-145.
11. Bagel-Boithias S., Sautou-Miranda V., Bourdeaux D., Tramier V., Boyer A., Chopineau J. Leaching of diethylhexylphtalate from multilayer tubing into etoposide infusion solutions. Am J Health Syst Pharm 2005, 62:182-188.
12. Loff S., Subotic U., Reinicke F., Wischmann H., Brade J. Extraction of Di-ethylhexyl-phthalate from perfusion lines of various material, length and brand by lipid emulsions. J Pediatr Gastroenterol Nutr 2004, 39:341-345.
13. Bourdeaux D., Sautou-Miranda V., Bagel-Boithias S., Boyer A., Chopineau J. Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl) phthalate released by multilayer infusion tubing. J Pharm Biomed Anal 2004, 35:57-64.
14. Société francophone nutrition clinique et métabolisme (SFNEP), Europharmat. Tubulures d'administration pour nutrition parentérale. Fiche de bon usage. Disponible sur ; 2007. http://www.euro-pharmat.com/.
15. Loff S., Kabs F., Subotic U., Schaible T., Reinecke F., Langbein M. Kinetics of diethylhexylphthalate extraction from polyvinylchloride-infusion lines. J Parenter Enteral Nutr 2002, 26:305-309.
16. Subotic U., Hannmann T., Kiss M., Brade J., Breitkopf K., Loff S. Extraction of the plasticizers diethylhexylphthalate and polyadipate from polyvinylchloride nasogastric tubes through gastric juice and feeding solution. J Pediatr Gastroenterol Nutr 2007, 44:71-76.
17. Shea K.M. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics 2003, 111:1467-1474.
18. Calafat A.M., Needham L.L., Silva M.J., Lambert G. Exposure to di-(2-ethylhexyl)phthalate among premature neonates in a neonatal intensive care unit. Pediatrics 2004, 113:429-434.
19. National Toxicology Program (NTP) Center for the Evaluation of Risks to Human Reproduction (CERHR). Monograph on the potential human reproductive and developmental effects of di-(2-ethylhexyl) phthalate (DEHP). NTP-CEHRHR; 2006.
20. Foster P.M. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl 2006, 29:140-147.
21. Welsh M., Saunders P.T., Fisken M., Scott H.M., Hutchison G.R., Smith L.B., et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008, 118:1479-1490.
22. David M.R., Moore M.R., Finney Dc, Guest D. Chronic toxicity of di(2-ethylhexyl)phthalate in mice. Toxicol Sci 2000, 58:377-385.
23. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., Calafat A.M., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005, 113:1056-1061.
24. Swan S.H. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in human. Environ Res 2008, 108:177-184.
25. Latini G., De Felice C., Presta G., Del Vecchio A., Paris I., Ruggieri F., et al. In utero exposure to di-(2-ethylhexyl)-phthalate and duration of human pregnancy. Environ Health Perspect 2003, 111:1783-1785.
26. Colon I., Caro D., Bourdony C.J., Rosario O. Identification of phthalate esters in the serum of young puerto rican girls with premature breast development. Environ Health Perspect 2000, 108:895-900.
27. Lomenick J.P., Calafat A.M., Melguizo Castro M.S., Mier R., Stenger P., Foster M.B., et al. Phthalate exposure and precocious puberty in females. J Pediatr 2010, 156:221-225.
28. Pant N., Shukla M., Kumar Patel D., Shukla Y., Mathur N., Kumar Gupta Y., et al. Correlation of phthalate exposures with semen quality. Toxicol Appl Pharmacol 2008, 231:112-116.
29. Hauser R., Meeker J.D., Susan D., Manori S.J., Calafat A.M. Altered semen quality in relation to urinary concentration of phthalate monoester and oxidative metabolites. Epidemiology 2006, 17:682-691.
30. Cobellis L., Latini G., De Felice C., Razzi S., Paris I., Ruggieri F., et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod 2003, 18:1512-1515.
31. Rais-Bahrami K., Nunez S., Revenis M.E., Luban N.L.C., Short B.L. Follow-up study of adolescents exposed to di-2-ethylhexyl phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environ Health Perspect 2004, 112:1339-1340.
32. Von Reeberg H., Hannman T., Subotic U., Brade J., Scaible T., Waag K.L., et al. Use of di(2-ethylhexyl)phthalate containing infusion systems increases the risk for cholestasis. Pediatrics 2009, 124:710-716.
33. US Food and Drug Administration. Public Health Notification. PVC Devices containing the plasticizer DEHP. Rockville, MD: FDA; 2002.
34. Scientific Committee on Medicinal Products and Medical Devices. Medical devices containing DEHP plasticised PVC; neonates and other groups possibly at risk from DEHP toxicity. Commission européenne; 2002.
35. Directive 2007/47/CE du Parlement européen et du Conseil du 5 septembre 2007 modifiant la directive 90/385/CEE du Conseil concernant le rapprochement des législations des États membres relatives aux dispositifs médicaux implantables actifs, la directive 93/42/CEE du Conseil relative aux dispositifs médicaux et la directive 98/8/CE concernant la mise sur le marché des produits biocides (JOUE 21/09/2007).
36. Agence française de sécurité sanitaire des produits de santé (Afssaps). Recommandations portant sur les phtalates dans les dispositifs médicaux. Afssaps; 2009.
37. Institut national de recherche et de sécurité pour la prévention des accidents du travail et des maladies professionnelles (INRS). Phtalate de di isononyle. FT 245. INRS; 2003.
38. Saillenfait A.M., Laudet-Hesbert A. Phtalates. EMC Toxicologie-Pathologie 2005, 2:1-13.
39. Barber E.D. Genetic toxicology testing of di(2-ethylhexyl)terephtalate. Environ Mol Mutagen 1994, 23:228-233.
40. Gray L.E., Ostby J., Price M., Veeramachaneni D.N., Parks L. Perinatal exposure to the phtalates DEHP, BBP, and DINP, but not DEP, DMP or DOTP, alters sexual differentiationof the male rat. Toxicol Sci 2000, 58:350-365.
41. Faber W.D., Deyo J.A., Stump D.G., Navarro L., Ruble K., Knapp J. Developmental toxicity and uterotrophic studies with di-2-ethylhexyl terephtalate. Birth Defects Res B Dev Reprod Toxicol 2007, 80:396-405.
42. Deyo J.A. Carcinogenicity and chronic toxicity of di-ethylhexyl terephtalate (DEHT) following a 2-year dietary exposure in Fischer 344 rats. Food Chem Toxicol 2008, 46:990-1005.
43. Kambia K., Dine T., Azar R., Gressier B., Luyckx M., Brunet C. Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl)trimellitate from haemodialysis tubing. Int J Pharm 2001, 229:139-146.
44. Ito R., Miura N., Iguchi H., Nakamura H., Ushiro N., Wakui N., et al. Determination of tris(2-ethylhexyl)trimellitate from PVC tube by LC-MS/MS. Int J Pharm 2008, 360:91-95.
45. Kambia N., Renault N., Dilly S., Farce A., Dine T., Gressier B., et al. Molecular modeling of phthlates - PPARs interactions. J Enzyme Inhib Med Chem 2008, 23:611-616.
46. Kambia K., Dine T., Gressier B., Dupin-Spriet T., Luyckx M., Brunet C. Evaluation of the direct toxicity of trioctyltrimellitate (TOTM), di(2-ethylhexyl)phthalate (DEHP) and their hydrolysis products on isolated rat hepatocytes. Int J Artif Organs 2004, 27:971-978.
47. Goulas A.E., Zygoura P., Karatapanis A., Georgantelis D., Kontominas M.G. Migration of di(2-ethylhexyl)adipate and acetyltributyl citrate plasticisers from food-grade PVC film into sweetened sesame paste (halawa tehineh): kinetic and penetration study. Food Chem Toxicol 2007, 45:585-591.
48. Babich MA. Review of exposure and toxicity data for phtalate substitutes. US Consumer Product Safety Commission. Consumer Product Safety Commission; 2010.
49. Welle F., Wolz G., Franz R. Migration of plasticizers from PVC tubes into enteral feeding solutions. Forsch Entwickl 2005, 3:17-21.
50. Europharmat. Guide pratique sur les phtalates. Disponible sur ; 2010. http://www.euro-pharmat.com/.